NCT00893217View on ClinicalTrials.gov

BEYOND Pilot Study

PHASE2CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

November 30, 2002

Study Completion Date

June 30, 2003

Conditions
Multiple SclerosisRelapsing-Remitting
Interventions
DRUG

Betaseron (Interferon beta-1b, BAY86-5046)

250 mcg

DRUG

Betaseron (Interferon beta-1b, BAY86-5046)

500 mcg

Trial Locations (14)

11794

Stony Brook

20037

Washington D.C.

27262

High Point

27710

Durham

37232

Nashville

40205

Louisville

66160

Kansas City

90095

Los Angeles

30309-1465

Atlanta

60637-1470

Chicago

48109-0330

Ann Arbor

89557-0035

Reno

27157-1009

Winston-Salem

43210-1240

Columbus

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT00893217 - BEYOND Pilot Study | Biotech Hunter | Biotech Hunter